⌘K

Login Start Free

Home/Filings/4/0001104659-20-081219

4//SEC Filing

Mann Brenda 4

Accession 0001104659-20-081219

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:15 PM ET

Size

4.8 KB

Accession

0001104659-20-081219

Insider Transaction Report

Form 4

Period: 2020-07-02

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2020-07-02$4.82/sh−94$453→ 17,845 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 07/01/2020.

Documents

1 file

4
tm2024119-1_4.xmlPrimary
FORM 4

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 4:15 PM ET
Size: 4.8 KB

View on SEC.gov